BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7947629)

  • 21. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.
    Yamaguchi K; Chijiiwa K; Noshiro H; Torata N; Kinoshita M; Tanaka M
    Hepatogastroenterology; 1999; 46(28):2575-81. PubMed ID: 10522044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precancerous conditions of pancreatic carcinoma.
    Lüttges J; Klöppel G
    J Hepatobiliary Pancreat Surg; 2000; 7(6):568-74. PubMed ID: 11180888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas.
    Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial anomalies in chronic pancreatitis as a risk factor of pancreatic cancer.
    Cylwik B; Nowak HF; Puchalski Z; Barczyk J
    Hepatogastroenterology; 1998; 45(20):528-32. PubMed ID: 9638443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters.
    Adachi T; Tajima Y; Kuroki T; Mishima T; Kitasato A; Fukuda K; Tsutsumi R; Kanematsu T
    J Surg Res; 2006 Nov; 136(1):106-11. PubMed ID: 16863651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma.
    Moskovitz AH; Linford NJ; Brentnall TA; Bronner MP; Storer BE; Potter JD; Bell RH; Rabinovitch PS
    Genes Chromosomes Cancer; 2003 Jun; 37(2):201-6. PubMed ID: 12696069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary tumors of the exocrine pancreas. Classification, overview, and recent contributions by immunohistochemistry and electron microscopy.
    Lack EE
    Am J Surg Pathol; 1989; 13 Suppl 1():66-88. PubMed ID: 2561251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of ras mutations in pancreatic diseases].
    Löhr M; Liebe S; Lowenfels AB
    Z Gastroenterol; 1998 Oct; 36(10):929-32. PubMed ID: 9846373
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ductal epithelial lesions and pancreatic adenocarcinoma].
    Bentjerodt R; Smok G
    Rev Med Chil; 1990 Oct; 118(10):1099-104. PubMed ID: 2152626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment.
    Esposito I; Seiler C; Bergmann F; Kleeff J; Friess H; Schirmacher P
    Pancreas; 2007 Oct; 35(3):212-7. PubMed ID: 17895840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological lesions of the pancreatic ducts. Significance of pyloric gland metaplasia in carcinogenesis of exocrine and endocrine pancreas.
    Kodama T; Mori W
    Acta Pathol Jpn; 1983 Jul; 33(4):645-60. PubMed ID: 6624447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of transforming growth factor beta by small duct epithelium in chronic, cancer-associated, obstructive pancreatitis: an in situ hybridization study and review of the literature.
    Fukumura Y; Suda K; Mitani K; Takase M; Kumasaka T
    Pancreas; 2007 Nov; 35(4):353-7. PubMed ID: 18090242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of Ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis.
    Tabata T; Fujimori T; Maeda S; Yamamoto M; Saitoh Y
    Int J Pancreatol; 1993 Dec; 14(3):237-44. PubMed ID: 8113625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of K-ras gene mutation at codon 12 by pancreatic duct brushing for pancreatic cancer.
    Liu F; Li ZS; Xu GM; Sun ZX; Zhou GX; Ren XX; Tu ZX; Gong YF
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):313-7. PubMed ID: 14599992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinico-pathological and histochemical studies on hypertrophic duct epithelium in human non-endocrine pancreas cancer.
    Hisata Y
    Bull Tokyo Med Dent Univ; 1979 Jun; 26(2):139-48. PubMed ID: 87280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K-ras mutation in focal proliferative lesions of human pancreas.
    Terhune PG; Phifer DM; Tosteson TD; Longnecker DS
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):515-21. PubMed ID: 9641496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
    Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
    Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pancreatic duct cell: proliferative capabilities, specific characteristics, metaplasia, isolation, and culture.
    Githens S
    J Pediatr Gastroenterol Nutr; 1988; 7(4):486-506. PubMed ID: 2456383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated solitary ducts (naked ducts) in adipose tissue: a specific but underappreciated finding of pancreatic adenocarcinoma and one of the potential reasons of understaging and high recurrence rate.
    Bandyopadhyay S; Basturk O; Coban I; Thirabanjasak D; Liang H; Altinel D; Adsay NV
    Am J Surg Pathol; 2009 Mar; 33(3):425-9. PubMed ID: 19092633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleolar organizer regions in exocrine pancreas in chronic pancreatitis and ductal adenocarcinoma. Diagnostic value and cytophysiologic correlate.
    Pollok A
    Gen Diagn Pathol; 1997 Feb; 142(3-4):199-209. PubMed ID: 9065584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.